Asia-Pacific Respiratory Device Market Trends, Segmentation, Growth, Analysis and Forecast 2023-2030

The Asia-Pacific respiratory device market was valued at around $6.1 billion in 2018 and is estimated to grow at a CAGR of around 6.7% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in North America. The Asia-Pacific respiratory devices market presents future opportunities for growth as the prevalence of respiratory diseases such as asthma and COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-respiratory-device-market

The Asia-Pacific respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Cipla Ltd., GlaxoSmithKline PLC, 3M Co., Novartis AG, Omron Healthcare Inc., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, In January 2018 Omron Healthcare Introduces Avail, a Wireless Device for Drug-Free Pain Relief. In January 2019 Omron Healthcare officially launches HeartGuide the first wearable blood pressure monitor, with new digital health service, HeartAdvisor.

Asia-Pacific Respiratory Device Market Segmentation

By Product

Therapeutic Devices
Diagnostic and Monitoring Devices
Consumables and Accessories

By End-User

Homecare
Hospitals and Clinics

A full report of European IoT in Healthcare Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-respiratory-device-market

Regional Analysis

China
Japan
India
Rest of Asia-Pacific

Company Profiles

3M Co.
Acorda Therapeutics, Inc.
Adamis Pharmaceuticals Corp.
Adherium Ltd.
Aradigm Corp.
AstraZeneca PLC
Beximo Pharmaceuticals Ltd.
BMC Medical Co., Ltd.
Boehringer Ingelheim International GmbH
Cipla Ltd.
GlaxoSmithKline PLC
Koninklijke Philips N.V.
Mylan N.V.
Novartis AG
Omron Healthcare Inc.
ResMed Corp.
Sunovion Pharmaceuticals
Teijin Pharma Ltd.
Teva Pharmaceuticals Industries Ltd.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.